39 related articles for article (PubMed ID: 20373934)
1. Serum CA-125 as a predictor in the early diagnosis of ectopic pregnancy in Vietnam - A case-control study.
Tran NBT; Cao TN; Nguyen QHV; Truong LGT; Tran LM; Tran Nguyen TN; Le TM
Placenta; 2023 Sep; 140():84-89. PubMed ID: 37549441
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of clinicodemographic, biochemical and metabolite variables to identify viable pregnancies in a symptomatic cohort during early gestation.
Hill CJ; Phelan MM; Dutton PJ; Busuulwa P; Maclean A; Davison AS; Drury JA; Tempest N; Horne AW; Gutiérrez EC; Hapangama DK
Sci Rep; 2024 May; 14(1):11172. PubMed ID: 38750192
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Serum CA-125 and Progesterone Levels with Ultrasound Markers in The Prediction of Pregnancy Outcome in Threatened Miscarriage.
Al Mohamady M; Fattah GA; Elkattan E; Bayoumy R; Hamed DA
Int J Fertil Steril; 2016; 9(4):506-11. PubMed ID: 26985338
[TBL] [Abstract][Full Text] [Related]
4. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis.
Pillai RN; Konje JC; Tincello DG; Potdar N
Hum Reprod Update; 2016; 22(2):228-39. PubMed ID: 26663220
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pregnancy outcomes with combined ultrasound scanning of yolk sacs and serum CA125 determinations in early threatened abortion.
Xie YJ; Chen M; Chen SJ
Clin Exp Obstet Gynecol; 2014; 41(2):186-9. PubMed ID: 24779249
[TBL] [Abstract][Full Text] [Related]
6. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum free beta-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies.
Noble PL; Snijders RJ; Abraha HD; Sherwood RA; Nicolaides KH
Br J Obstet Gynaecol; 1997 Jun; 104(6):741-3. PubMed ID: 9197882
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis.
Chen K; Liu X; Meng X; Li H; Yang C; Wang X
Front Pharmacol; 2023; 14():1138968. PubMed ID: 37332346
[No Abstract] [Full Text] [Related]
9. Performance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients: a systematic review and meta-analysis.
Ghaedi B; Cheng W; Ameri S; Abdulkarim K; Costain N; Zia A; Thiruganasambandamoorthy V
CJEM; 2022 Sep; 24(6):611-621. PubMed ID: 35921048
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis.
Wu H; Zhang S; Lin X; He J; Wang S; Zhou P
Reprod Biol Endocrinol; 2021 Nov; 19(1):165. PubMed ID: 34732210
[TBL] [Abstract][Full Text] [Related]
11. Baseline Levels of Serum Progesterone and the First Trimester Pregnancy Outcome in Women with Threatened Abortion: A Retrospective Cohort Study.
Deng Y; Chen C; Chen S; Mai G; Liao X; Tian H; Liu W; Ji S; Liu Y; Gao J; Luo S
Biomed Res Int; 2020; 2020():8780253. PubMed ID: 32190685
[TBL] [Abstract][Full Text] [Related]
12. Hormonal and reproductive factors and reduction in the risk of colorectal cancer.
Rennert G; Rennert HS; Pinchev M; Gruber SB; Lavie O
Eur J Cancer Prev; 2020 May; 29(3):229-237. PubMed ID: 31714342
[TBL] [Abstract][Full Text] [Related]
13. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.
Ku CW; Allen JC; Lek SM; Chia ML; Tan NS; Tan TC
BMC Pregnancy Childbirth; 2018 Sep; 18(1):360. PubMed ID: 30185145
[TBL] [Abstract][Full Text] [Related]
14. Progestogen for treating threatened miscarriage.
Wahabi HA; Fayed AA; Esmaeil SA; Bahkali KH
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005943. PubMed ID: 30081430
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis.
Lee HJ; Park TC; Kim JH; Norwitz E; Lee B
Biomed Res Int; 2017; 2017():3616875. PubMed ID: 29392134
[TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.
Chan DM; Cheung KW; Yung SS; Lee VC; Li RH; Ng EH
Trials; 2016 Aug; 17(1):408. PubMed ID: 27534747
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic Value of β-Human Chorionic Gonadotropin, Progesterone, and Ischemia-Modified Albumin and Their Combined Use in the Prediction of First Trimester Abortions.
Osmanağaoğlu MA; Karahan SC; Aran T; Güven S; Turgut E; Menteşe A; Bozkaya H
Int Sch Res Notices; 2014; 2014():846531. PubMed ID: 27437482
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of beta-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions.
Osmanağaoğlu MA; Erdoğan I; Eminağaoğlu S; Karahan SC; Ozgün S; Can G; Bozkaya H
J Obstet Gynaecol; 2010 Apr; 30(3):288-93. PubMed ID: 20373934
[TBL] [Abstract][Full Text] [Related]
19. Predictive power progesterone combined with beta human chorionic gonadotropin measurements in the outcome of threatened miscarriage.
Duan L; Yan D; Zeng W; Yang X; Wei Q
Arch Gynecol Obstet; 2011 Mar; 283(3):431-5. PubMed ID: 20107822
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
